Literature DB >> 15004047

Temperature-mediated heteroduplex analysis for detection of pncA mutations associated with pyrazinamide resistance and differentiation between Mycobacterium tuberculosis and Mycobacterium bovis by denaturing high- performance liquid chromatography.

Amr M Mohamed1, Dhundy R Bastola, Glenn P Morlock, Robert C Cooksey, Steven H Hinrichs.   

Abstract

The goal of this study was to apply temperature-mediated heteroduplex analysis using denaturing high-performance liquid chromatography to identify pyrazinamide (PZA) resistance in Mycobacterium tuberculosis isolates and simultaneously differentiate between M. tuberculosis and Mycobacterium bovis. Features that contributed to an optimal assay included the use of two different reference probes for the pncA gene targets from wild-type M. tuberculosis and wild-type M. bovis, optimization of the column temperature, increasing the starting concentration of the elution buffer, and reducing the rate of elution buffer increase (slope). A total of 69 strains were studied, including 48 wild-type M. tuberculosis strains (13 were PZA-resistant strains) and 21 M. bovis strains (8 were BCG strains). In all isolates tested, wild-type M. tuberculosis generated a single-peak pattern when mixed with the M. tuberculosis probe and a double-peak pattern with the M. bovis probe. In contrast, all M. bovis isolates generated a double-peak pattern when mixed with the M. tuberculosis probe and a single-peak pattern with the M. bovis probe. PZA-resistant mutant M. tuberculosis isolates generated characteristic patterns that were easily distinguishable from both wild-type M. tuberculosis and M. bovis isolates. Chromatographic patterns generated by the two reference probes allowed the rapid detection of PZA resistance with the simultaneous ability to distinguish between M. tuberculosis and M. bovis. This approach may allow the detection of drug resistance-associated mutations, with potential application to clinical and epidemiological aspects of tuberculosis control.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004047      PMCID: PMC356819          DOI: 10.1128/JCM.42.3.1016-1023.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Analysis and purification of nucleic acids by ion-pair reversed-phase high-performance liquid chromatography.

Authors:  K H Hecker; S M Green; K Kobayashi
Journal:  J Biochem Biophys Methods       Date:  2000-11-20

2.  Temperature-mediated heteroduplex analysis performed by using denaturing high-performance liquid chromatography to identify sequence polymorphisms in Mycobacterium tuberculosis complex organisms.

Authors:  Robert C Cooksey; Glenn P Morlock; Brian P Holloway; Josef Limor; Michael Hepburn
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

3.  Improved efficiency of mutation detection by denaturing high-performance liquid chromatography using modified primers and hybridization procedure.

Authors:  G Narayanaswami; P D Taylor
Journal:  Genet Test       Date:  2001

4.  Pulmonary tuberculosis due to multidrug-resistant Mycobacterium bovis in a healthy host.

Authors:  Pablo Robles Ruíz; Jaime Esteban; Manuel L Fernández Guerrero
Journal:  Clin Infect Dis       Date:  2002-07-15       Impact factor: 9.079

5.  Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States.

Authors:  M M Hannan; E P Desmond; G P Morlock; G H Mazurek; J T Crawford
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

6.  Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion.

Authors:  Enrico Tortoli; Marta Benedetti; Alessandra Fontanelli; M Tullia Simonetti
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

7.  Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA.

Authors:  N Lemaitre; W Sougakoff; C Truffot-Pernot; V Jarlier
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

8.  Pyrazinamide susceptibility and amidase activity of tubercle bacilli.

Authors:  K Konno; F M Feldmann; W McDermott
Journal:  Am Rev Respir Dis       Date:  1967-03

9.  Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis.

Authors:  G P Morlock; J T Crawford; W R Butler; S E Brim; D Sikes; G H Mazurek; C L Woodley; R C Cooksey
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

10.  Evaluation of BACTEC MGIT 960 and BACTEC 460TB systems for recovery of mycobacteria from clinical specimens of a university hospital with low incidence of tuberculosis.

Authors:  L Leitritz; S Schubert; B Bücherl; A Masch; J Heesemann; A Roggenkamp
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

View more
  7 in total

1.  Direct detection and identification of Mycobacterium tuberculosis and Mycobacterium bovis in bovine samples by a novel nested PCR assay: correlation with conventional techniques.

Authors:  A Mishra; A Singhal; D S Chauhan; V M Katoch; K Srivastava; S S Thakral; S S Bharadwaj; V Sreenivas; H K Prasad
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

Review 2.  Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses.

Authors:  Kwok Chiu Chang; Wing Wai Yew; Ying Zhang
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

3.  Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing.

Authors:  Ruiru Shi; Jianyuan Zhang; Chuanyou Li; Yuko Kazumi; Isamu Sugawara
Journal:  J Clin Microbiol       Date:  2006-10-11       Impact factor: 5.948

4.  Detection by denaturing gradient gel electrophoresis of pncA mutations associated with pyrazinamide resistance in Mycobacterium tuberculosis isolates from the United States-Mexico border region.

Authors:  Mark T McCammon; John S Gillette; Derek P Thomas; Srinivas V Ramaswamy; Ishmael I Rosas; Edward A Graviss; Jan Vijg; Teresa N Quitugua
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

5.  Toward a better understanding of the genomic region harboring Fusarium head blight resistance QTL Qfhs.ndsu-3AS in durum wheat.

Authors:  Xianwen Zhu; Shaobin Zhong; Shiaoman Chao; Yong Qiang Gu; Shahryar F Kianian; Elias Elias; Xiwen Cai
Journal:  Theor Appl Genet       Date:  2015-09-18       Impact factor: 5.699

6.  A novel identification scheme for genus Mycobacterium, M. tuberculosis complex, and seven mycobacteria species of human clinical impact.

Authors:  I Pérez-Martínez; A Ponce-De-León; M Bobadilla; N Villegas-Sepúlveda; M Pérez-García; J Sifuentes-Osornio; J A González-y-Merchand; T Estrada-García
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-02       Impact factor: 3.267

7.  Pyrazinamide susceptibility testing of Mycobacterium tuberculosis by high resolution melt analysis.

Authors:  Suporn Pholwat; Suzanne Stroup; Jean Gratz; Varittha Trangan; Suporn Foongladda; Happiness Kumburu; Saumu Pazia Juma; Gibson Kibiki; Eric Houpt
Journal:  Tuberculosis (Edinb)       Date:  2013-11-01       Impact factor: 3.131

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.